Medical Condition News

RSS

Binaytara Foundation, UIC partner to develop Nepal's first blood and marrow transplant unit

The University of Illinois at Chicago and the Binaytara Foundation have partnered to develop Nepal's first blood and marrow transplant unit and to organize the country's first international conference on blood cancers.

12 Sep 2013

Study: People who get occasional migraines are more likely to be obese

People who get occasional migraines are more likely to be obese than people who do not have migraines, according to a study published in the September 11, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

12 Sep 2013

Psychiatrist documents how schizophrenia impacts brain tissue

It's hard to fully understand a mental disease like schizophrenia without peering into the human brain. Now, a study by University of Iowa psychiatry professor Nancy Andreasen uses brain scans to document how schizophrenia impacts brain tissue as well as the effects of anti-psychotic drugs on those who have relapses.

12 Sep 2013

Kiadis five-year follow-up phase I/II clinical study confirms long-term safety, efficacy of ATIR

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that the five-year follow-up of patients with high-risk malignancies from its Phase I/II clinical study confirms long-term safety and efficacy of ATIR™ over a broad dose range.

12 Sep 2013

Euclid Systems, Wenzhou Medical University Eye Hospital sign cooperation agreement

Euclid Systems Corporation today announced the signing of a cooperation agreement with Wenzhou Medical University Eye Hospital.

12 Sep 2013

Ventana gets CFDA approval for VENTANA ALK immunohistochemistry assay

Ventana Medical Systems, Inc., a member of the Roche Group, today announced the approval of the VENTANA ALK immunohistochemistry assay by the Chinese Food and Drug Administration as a companion diagnostic to aid in the identification of patients for Pfizer's CFDA-approved oncology product XALKORI (crizotinib).

12 Sep 2013

Patients with longer-lasting chest pain more likely to have heart attack

Patients with longer-lasting chest pain are more likely having a heart attack than those with pain of a shorter duration, according to a study by researchers at Henry Ford Hospital.

12 Sep 2013

New technique provides better understanding of factors causing Smith-Lemli-Opitz Syndrome

The first proteomic analysis of an animal model of a rare, sometimes deadly birth defect, Smith-Lemli-Opitz Syndrome (SLOS), has revealed that the molecular mechanisms that cause it are more complex than previously understood.

12 Sep 2013

New study shows advances in care for women who suffer from recurrent miscarriage

A team of researchers, led by the University of Warwick, have published new data that could prove vital for advances in care for women who suffer from recurrent miscarriage.

12 Sep 2013

MicroBiome Therapeutics' NM504 eliminates diarrhea caused by metformin in type 2 diabetes patient

MicroBiome Therapeutics LLC, a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504. NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.

11 Sep 2013

Umbilical cord mesenchymal stem cells may have targeting capacity for glioma

Glioblastoma is the most common ma-lignant primary brain tumor in adults. The aggressive growth manner, characterized by marked angiogenesis and extensive tumor cell invasion into normal brain parenchyma with frequent formation of tumor microsatellites at distal sites, makes eradication impossible even after extensive microsurgical resection combined with current standard chemoradiation and adjuvant temozolomide.

11 Sep 2013

University student shares experiences about managing severe allergy

Ahead of the first term back for university undergraduates this month, the Anaphylaxis Campaign has released a short film on their YouTube channel.

11 Sep 2013

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine’s efficacy in treating asthma patients and is not currently approved for this indication.

11 Sep 2013

Scientists use nanodiamonds to boost delivery of drug to leukemic cells

By binding multiple molecules of a common leukemia drug with nanodiamonds, scientists from the National University of Singapore (NUS) and University of California, Los Angeles (UCLA) managed to boost the delivery of the drug to leukemic cells and retain the drug within the cells to combat the cancer.

11 Sep 2013

UK and US policies risk conscription into unwanted 'war against dementia'

A political drive, led by the UK and US, to screen older people for minor memory changes (often called mild cognitive impairment or pre-dementia) is leading to unnecessary investigation and potentially harmful treatment for what is arguably an inevitable consequence of ageing, warn experts on bmj.com today.

11 Sep 2013

Financial incentives on hypertension care shows increased blood pressure control

In an examination of the effect of financial incentives on hypertension care at 12 outpatient clinics, physician-level (individual) financial incentives, but not practice-level or combined incentives, resulted in greater blood pressure control or appropriate response to uncontrolled blood pressure, according to a study in the September 11 issue of JAMA.

11 Sep 2013

Expression of stress protein induced by ischemia/reperfusion injury, say researchers

Spinal cord ischemia/reperfusion injury is a stress injury to the spinal cord. Therefore, research on the expression of stress-related protein in neurons could be of great significance for the pathological mechanism and control measures for spinal cord ischemia/reperfusion injury.

11 Sep 2013

Strides therapeutic approach helps autistic children reach breakthroughs in communication

Luke, a 7-year-old autistic child had primarily only expressed requests to his parents (e.g., I want a drink), but this past year he was given a 1-pound iPad, introduced to a 1,000 pound horse and a special program called Strides©.

11 Sep 2013

Study shows huge cost implications in getting injured patients to appropriate trauma hospitals

During a three-year period in seven metropolitan areas in the western United States, the emergency medical services system sent more than 85,000 injured patients to major trauma hospitals who didn't need to go there - costing the health care system more than $130 million per year, according to an Oregon Health & Science University study published today in the journal Health Affairs.

11 Sep 2013

Rutgers scientist finds important clue on origins of multiple sclerosis

The search for the cause of multiple sclerosis, a debilitating disease that affects up to a half million people in the United States, has confounded researchers and medical professionals for generations. But Steven Schutzer, a physician and scientist at Rutgers New Jersey Medical School, has now found an important clue why progress has been slow - it appears that most research on the origins of MS has focused on the wrong part of the brain.

11 Sep 2013

Medical Condition News

Binaytara Foundation, UIC partner to develop Nepal's first blood and marrow transplant unit

Study: People who get occasional migraines are more likely to be obese

Psychiatrist documents how schizophrenia impacts brain tissue

Kiadis five-year follow-up phase I/II clinical study confirms long-term safety, efficacy of ATIR

Euclid Systems, Wenzhou Medical University Eye Hospital sign cooperation agreement

Ventana gets CFDA approval for VENTANA ALK immunohistochemistry assay

Patients with longer-lasting chest pain more likely to have heart attack

New technique provides better understanding of factors causing Smith-Lemli-Opitz Syndrome

New study shows advances in care for women who suffer from recurrent miscarriage

MicroBiome Therapeutics' NM504 eliminates diarrhea caused by metformin in type 2 diabetes patient

Umbilical cord mesenchymal stem cells may have targeting capacity for glioma

University student shares experiences about managing severe allergy

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Scientists use nanodiamonds to boost delivery of drug to leukemic cells

UK and US policies risk conscription into unwanted 'war against dementia'

Financial incentives on hypertension care shows increased blood pressure control

Expression of stress protein induced by ischemia/reperfusion injury, say researchers

Strides therapeutic approach helps autistic children reach breakthroughs in communication

Study shows huge cost implications in getting injured patients to appropriate trauma hospitals

Rutgers scientist finds important clue on origins of multiple sclerosis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News